PPAR
The peroxisome proliferator-activated receptors (PPARs), belonging to the nuclear receptor superfamily, are a group of nuclear receptor proteins that are composed of three isoforms, including PPARγ, PPARα and PPARδ, encoded by separate genes. PPARs have a modular structure characterized by the presence of two highly conserved domains, including the DNA binding domain (DBD) of two zinc fingers and the ligand binding domain (LBD) of 13 α-helices and a small 4-stranded β-sheet. PPARs are ligand-regulated transcription factors controlling gene expression by binding to specific response elements (PPREs) within promoters, where PPARs bind as heterodimers with a retinoid X receptor and interact with cofactors upon binding leading to the increasing of rate of transcription initiation.
- C4892 MCC-555Summary: thiazolidinedione class anti-diabetic compound,a novel PPARα/γ dual ligand
- C5151 CetabenSummary: unique,PPARα-independent peroxisome proliferator
- C5263 LT175Summary: dual PPARα/γ ligand
- C5280 3-Thiatetradecanoic AcidSummary: activator of PPAR
- C5631 Glycerophospho-N-Oleoyl EthanolamineSummary: precursor of oleoyl ethanolamide (OEA)
- C5712 DG-172 (hydrochloride)Summary: orally available inverse agonist of PPARβ/δ
- C5557 SR 1824Summary: non-agonist PPARγ ligand
- C5435 G3335Summary: PPARγ antagonist
- C5572 SR 2595Summary: inverse agonist of PPARγ
- B2117 PioglitazoneSummary: PPAR agonist